To address this unmet need and identify the preferred administration sequence of the combination of cancer vaccine and ICI, we performed animal experiments using mice harboring tumors poorly responsive to the initial anti-PD-1 treatment (Figures 5A and 5B). This evidence concerns the gene PDCD1 and cancer.